Safety and effectiveness of sedation during and after diagnostic esophagogastroduodenoscopy: randomiszed comparisons between propofol and midazolam.
Not Applicable
- Conditions
- pper gastrointestinal disease
- Registration Number
- JPRN-UMIN000009142
- Lead Sponsor
- Tokyo east hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Assigned to American Society of Anesthesiologists classes III and IV, severe liver dysfunction, pregnant, paresis after cerebral infarction, overweight (body weight > 100kg), allergic to the drug used or its components (soybeans or eggs), emergency procedure Others who could not accept this study concept or was estimated as inadequate for this study by the primary doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Vital signs, respiratory depression, full recovery (conscious level, motor function), the occurrence of adverse events within 24h after procedure Effectiveness: Overall satisfaction of procedures from patients' questionnaires
- Secondary Outcome Measures
Name Time Method Successful procedure, depth of anesthesia, means of transfer after procedure and any other complications